Novel multiplex real-time PCR system using the SNP technology for the simultaneous diagnosis of Chlamydia trachomatis, Ureaplasma parvum and Ureaplasma urealyticum and genetic typing of serovars of C. trachomatis and U. parvum in NGU

Mol Cell Probes. 2011 Feb;25(1):55-9. doi: 10.1016/j.mcp.2010.12.001. Epub 2010 Dec 15.

Abstract

To explore the possibilities of a novel multiplex real-time PCR system for rapid diagnosis, genetic typing of serovars and clinical application in NGU, we developed a multiplex real-time PCR system for the simultaneous diagnosis of Chlamydia trachomatis, Ureaplasma parvum and Ureaplasma urealyticum and molecular detection of serovars of C. trachomatis and U. parvum in NGU using the SNP technology and TaqMan-LNA probe. In 57 pathogen-positive clinical specimens, we identified the following C. trachomatis serovars: D (20.05%, 12/57), E (36.84%, 21/57), F (19.30%, 11/57), G (8.77%, 5/57), H (5.26%, 3/57), J (3.51%, 2/57), and K (5.26%, 3/57). In 115 pathogen-positive clinical specimens, we identified the following U. parvum serovars: 1 (0.87%, 2/115), 3 (55.65%, 64/115), 6 (20.87%, 24/115) and 14 (21.74%, 25/115). Our fast pathogen diagnosis and serotyping assay using real-time TaqMan-LNA PCR may improve our ability to study the pathogenesis and epidemiology of NGU.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chlamydia Infections / diagnosis*
  • Chlamydia Infections / microbiology
  • Chlamydia trachomatis / classification
  • Chlamydia trachomatis / genetics*
  • DNA Probes
  • Female
  • Genotype
  • Humans
  • Male
  • Polymerase Chain Reaction
  • Polymorphism, Single Nucleotide
  • Serotyping / methods*
  • Ureaplasma / classification
  • Ureaplasma / genetics*
  • Ureaplasma Infections / diagnosis*
  • Ureaplasma Infections / microbiology
  • Ureaplasma urealyticum / classification
  • Ureaplasma urealyticum / genetics
  • Urethritis / diagnosis*

Substances

  • DNA Probes